AgeX Therapeutics, Inc. Made Big Gain
Wed, Jun 28, 2023 at 07:40 PM
AgeX Therapeutics, Inc. (AGE:NYSEMKT) soared at $0.87, representing a gain of 32.3%. On Wed, Jun 28, 2023, AGE:NYSEMKT touched a New 2-Week High of $0.87. From Wed, Jun 14, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
About AgeX Therapeutics, Inc. (AGE:NYSEMKT)
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop innovative medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1 and AGEX-BAT1. And iTR drug-based therapeutic candidates in development are AGEX-iTR1547 and Renelon.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 80%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 69.27%
- Signature Bank (SBNY:NASDAQ), 61.79%
- Knightscope Inc. (KSCP:NASDAQ), 52.15%
- Joby Aviation Inc. (JOBY:NYSE), 40.22%
- Kaleyra Inc. (KLR:NYSE), 39.38%
- Centogene N.V. (CNTG:NASDAQ), 33.9%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 33.86%
- Trio Petroleum Corp. (TPET:NYSEMKT), 33.64%
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 32.27%